AVA
Atlas Venture Advisors Portfolio holdings
AUM
$424M
This Quarter Return
-2.72%
1 Year Return
+0.16%
3 Year Return
+108.89%
5 Year Return
+64.67%
10 Year Return
–
AUM
$845M
AUM Growth
+$845M
(-12%)
Cap. Flow
-$86.6M
Cap. Flow
% of AUM
-10.26%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
1
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
TBIO
Translate Bio, Inc. Common Stock
TBIO
|
$51.6M |
| 2 |
DraftKings
DKNG
|
$35.1M |
Sector Composition
| 1 | Communication Services | 59.8% |
| 2 | Consumer Discretionary | 37.38% |
| 3 | Healthcare | 2.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Integral Ad Science
IAS
$1.49B
| $469M | 55.51% | 22,722,770 | – | – |
|
|
2
DraftKings
DKNG
$23.8B
| $316M | 37.38% | 6,555,608 -728,400 | -10% | -$35.1M |
|
3
Snap
SNAP
$12.1B
| $18.1M | 2.15% | 245,559 | – | – |
|
4
Roku
ROKU
$14.2B
| $18.1M | 2.14% | 57,707 | – | – |
|
|
BCYC
5
Bicycle Therapeutics
BCYC
$511M
| $12.8M | 1.52% | 307,696 | – | – |
|
|
FSTX
6
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $4.21M | 0.5% | 574,996 | – | – |
|
7
Viridian Therapeutics
VRDN
$1.5B
| $3.45M | 0.41% | 209,505 | – | – |
|
8
Larimar Therapeutics
LRMR
$310M
| $3.37M | 0.4% | 292,184 | – | – |
|
|
TBIO
9
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| – | – | -1,872,115 | Closed | -$51.6M |
|